BRPI0912099A2 - preparação percutaneamente absorvível - Google Patents

preparação percutaneamente absorvível

Info

Publication number
BRPI0912099A2
BRPI0912099A2 BRPI0912099A BRPI0912099A BRPI0912099A2 BR PI0912099 A2 BRPI0912099 A2 BR PI0912099A2 BR PI0912099 A BRPI0912099 A BR PI0912099A BR PI0912099 A BRPI0912099 A BR PI0912099A BR PI0912099 A2 BRPI0912099 A2 BR PI0912099A2
Authority
BR
Brazil
Prior art keywords
absorbable preparation
percutaneously absorbable
percutaneously
preparation
absorbable
Prior art date
Application number
BRPI0912099A
Other languages
English (en)
Inventor
Akinori Hanatani
Hitoshi Akemi
Junichi Sekiya
Sachiko Sakamoto
Sumiyo Maruyama
Original Assignee
Eisai R&D Man Co Ltd
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd, Nitto Denko Corp filed Critical Eisai R&D Man Co Ltd
Publication of BRPI0912099A2 publication Critical patent/BRPI0912099A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0912099A 2008-05-30 2009-05-28 preparação percutaneamente absorvível BRPI0912099A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12901008P 2008-05-30 2008-05-30
JP2008143591 2008-05-30
PCT/JP2009/059798 WO2009145269A1 (ja) 2008-05-30 2009-05-28 経皮吸収製剤

Publications (1)

Publication Number Publication Date
BRPI0912099A2 true BRPI0912099A2 (pt) 2015-10-06

Family

ID=41377139

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912099A BRPI0912099A2 (pt) 2008-05-30 2009-05-28 preparação percutaneamente absorvível

Country Status (10)

Country Link
US (1) US20100010043A1 (pt)
EP (1) EP2279740A4 (pt)
JP (1) JP5421252B2 (pt)
KR (1) KR20110020788A (pt)
CN (1) CN102046171B (pt)
BR (1) BRPI0912099A2 (pt)
CA (1) CA2725484A1 (pt)
RU (1) RU2483729C2 (pt)
TW (1) TW201002369A (pt)
WO (1) WO2009145269A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5110712B2 (ja) * 2006-12-01 2012-12-26 日東電工株式会社 ドネペジル含有貼付製剤の経時的な変色を抑制する方法
RU2445953C2 (ru) * 2006-12-01 2012-03-27 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
US8294420B2 (en) * 2009-09-29 2012-10-23 Schneider Electric USA, Inc. Kiosk vehicle charging and selecting systems
US8840922B2 (en) * 2009-10-21 2014-09-23 Teikoku Seiyaku Co., Ltd. Transdermally absorbable donepezil-containing preparation
JP2012236773A (ja) * 2009-12-16 2012-12-06 Goto Takeshi 抗認知症薬物の経皮吸収製剤
JP5795264B2 (ja) * 2009-12-16 2015-10-14 後藤 武 抗認知症薬物の経皮吸収製剤
US20120283670A1 (en) * 2009-12-16 2012-11-08 Takeshi Ito Percutaneous absorption preparation comprising anti-dementia drug
JP2012031071A (ja) * 2010-07-28 2012-02-16 Nitto Denko Corp 貼付剤および貼付製剤
JP2014194731A (ja) * 2012-12-11 2014-10-09 Toshiba Tec Corp 電子レシートシステム、商品販売データ処理装置、電子レシート管理サーバ、情報処理装置およびプログラム
US9277191B2 (en) 2012-12-12 2016-03-01 Schneider Electric USA, Inc. Security monitoring systems, methods and devices for electric vehicle charging stations
WO2016190002A1 (ja) * 2015-05-26 2016-12-01 ニプロ株式会社 貼付剤

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US4956391A (en) * 1988-08-17 1990-09-11 Sapse Alfred T Protected complex of procaine for the treatment of symptoms from narcotics addiction, tinnitus and alzheimer's disease
JP2593560B2 (ja) 1988-12-26 1997-03-26 オリンパス光学工業株式会社 内視鏡
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5919827A (en) * 1990-07-11 1999-07-06 Sepracor Inc. Method for treating asthma using optically pure R(-) salmeterol
US6010715A (en) * 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
HU228434B1 (en) * 1995-06-07 2013-03-28 Ortho Mcneil Pharm Inc Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen
EP0900565B1 (en) * 1997-01-07 2004-10-27 Teijin Limited Patch containing isosorbide dinitrate
US5981549A (en) * 1997-02-14 1999-11-09 Synapse Pharmaceutical International Method for controlling or alleviating the symptoms of respiratory disease and allergies
EP0971713B1 (en) * 1997-03-03 2003-05-28 Eisai Co., Ltd. Use of cholinesterase inhibitors to treat disorders of attention
US5812056A (en) * 1997-05-09 1998-09-22 Golden Eagle Electronics Manufactory Ltd. Child locating and monitoring device
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US6193993B1 (en) * 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
IT1299566B1 (it) * 1998-07-17 2000-03-16 Ifi Istituto Farmacoterapico I Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina
KR100764520B1 (ko) * 1998-08-28 2007-10-09 에자이 알앤드디 매니지먼트 가부시키가이샤 고미 등을 경감한 의약조성물
TWI233810B (en) * 1999-02-19 2005-06-11 Hisamitsu Pharmaceutical Co A paster sheet
US20020192243A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
US6294999B1 (en) * 1999-12-29 2001-09-25 Becton, Dickinson And Company Systems and methods for monitoring patient compliance with medication regimens
WO2001052823A2 (en) * 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
US20030153598A1 (en) * 2000-07-25 2003-08-14 Raymond Pratt Methods for treating Parkinson's disease with cholinesterase inhibitors
AU2001249091A1 (en) * 2000-03-03 2001-09-17 Eisai Co. Ltd. Novel methods using cholinesterase inhibitors
US6242003B1 (en) * 2000-04-13 2001-06-05 Novartis Ag Organic compounds
DE10021688A1 (de) * 2000-05-05 2001-11-15 Hassan Jomaa Gene des 1-Desoxy-D-xylulose-Biosynthesewegs
US20020052373A1 (en) * 2000-10-26 2002-05-02 Zorn Stevin H. Combination treatment for dementia or cognitive deficits associated with alzheimer's disease and parkinson's disease
SI20848A (sl) * 2001-03-14 2002-10-31 Lek, Tovarna Farmacevtskih In Kemijskih Izdelkov, D.D. Farmacevtska formulacija, ki vsebuje atorvastatin kalcij
CZ20033456A3 (en) * 2001-06-22 2004-07-14 Pfizer Products Inc. Pharmaceutical compositions comprising adsorbates of amorphous drug
US20040241240A1 (en) * 2001-08-10 2004-12-02 Takaaki Terahara Percutaneous absorption preparations
JP5021124B2 (ja) * 2001-08-29 2012-09-05 日東電工株式会社 医療用粘着組成物、それを用いた医療用粘着テープおよび経皮吸収用テープ製剤
EP1423127A1 (en) * 2001-08-30 2004-06-02 Ortho-Mcneil Pharmaceutical, Inc. Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
WO2003024450A1 (en) * 2001-09-20 2003-03-27 Eisai Co., Ltd. Methods for treating prion diseases
US20040258741A1 (en) * 2001-10-17 2004-12-23 Takaaki Terahara Percutaneous absorption preparations
WO2003032914A2 (en) * 2001-10-17 2003-04-24 Eisai Co., Ltd. Methods for treating substance abuse with cholinesterase inhibitors
CA2475385A1 (en) * 2002-02-07 2003-08-14 Eisai Co., Ltd. Hair growth promoting agent, percutaneously applied preparation, and hair growth promoting method
US20070053976A1 (en) * 2002-05-17 2007-03-08 Eisai R & D Management Co., Ltd. Novel combination of drugs as antidepressant
WO2004034963A2 (en) * 2002-05-17 2004-04-29 Eisai Co., Ltd. Methods and compositions using cholinesterase inhibitors
US20030225031A1 (en) * 2002-05-21 2003-12-04 Quay Steven C. Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid
JP4323138B2 (ja) * 2002-06-05 2009-09-02 日東電工株式会社 経皮吸収型製剤およびその製造方法
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
EP1670433B1 (en) * 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
DK1675591T3 (da) * 2003-10-16 2011-11-14 Neurosearch As Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
US20050232990A1 (en) * 2003-12-31 2005-10-20 Garth Boehm Donepezil formulations
US20070158227A1 (en) * 2004-01-30 2007-07-12 Satoshi Amano Plaster enclosing packaging bag
US20070128262A1 (en) * 2004-01-30 2007-06-07 Satoshi Amano Package containing adhesive patch and method of inhibiting drug migration
US20070166360A1 (en) * 2004-03-31 2007-07-19 Kowa Co., Ltd. External preparation
US20080038328A1 (en) * 2004-05-28 2008-02-14 Naruhito Higo Pasting Preparation
ATE413166T1 (de) * 2004-11-22 2008-11-15 Hisamitsu Pharmaceutical Co Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US20070129402A1 (en) 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
WO2006082728A1 (ja) * 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤
CA2548864C (en) * 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
JP5025998B2 (ja) * 2005-06-06 2012-09-12 日東電工株式会社 経皮吸収製剤
JP4999366B2 (ja) * 2005-06-06 2012-08-15 日東電工株式会社 経皮吸収製剤
EP1731143B1 (en) * 2005-06-06 2008-11-26 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure
CA2610757A1 (en) * 2005-06-10 2006-12-14 Transpharma Medical, Ltd. Patch for transdermal drug delivery
JP4950510B2 (ja) * 2006-02-16 2012-06-13 久光製薬株式会社 経皮吸収製剤
CN101432383B (zh) * 2006-04-28 2013-05-01 狮王株式会社 非水性粘合剂组合物、贴剂和贴剂的制备方法
IN266817B (pt) * 2006-05-08 2015-06-03 Teikoku Seiyaku Kk
JP5097359B2 (ja) * 2006-05-09 2012-12-12 久光製薬株式会社 ドネペジル経皮吸収型製剤
US20090324142A1 (en) * 2006-06-16 2009-12-31 Toyo Aluminium Kabushiki Kaisha Packaging material and bag for packaging of medicinal product
WO2008001200A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal composition having enhanced color stability
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
WO2008044336A1 (en) * 2006-10-11 2008-04-17 Hisamitsu Pharmaceutical Co., Inc. Crystal-containing adhesive preparation
RU2445953C2 (ru) * 2006-12-01 2012-03-27 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
JP5110712B2 (ja) * 2006-12-01 2012-12-26 日東電工株式会社 ドネペジル含有貼付製剤の経時的な変色を抑制する方法
EP2638906A1 (en) * 2006-12-01 2013-09-18 Nitto Denko Corporation Stabilized adhesive preparation containing donepezil
JP2008143591A (ja) 2006-12-13 2008-06-26 Kau Pack Kk 自立袋
JP5193674B2 (ja) * 2007-06-01 2013-05-08 日東電工株式会社 貼付剤および貼付製剤
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него

Also Published As

Publication number Publication date
JP5421252B2 (ja) 2014-02-19
CA2725484A1 (en) 2009-12-03
CN102046171A (zh) 2011-05-04
US20100010043A1 (en) 2010-01-14
EP2279740A4 (en) 2011-12-14
RU2483729C2 (ru) 2013-06-10
RU2010148787A (ru) 2012-07-10
WO2009145269A1 (ja) 2009-12-03
JPWO2009145269A1 (ja) 2011-10-13
KR20110020788A (ko) 2011-03-03
EP2279740A1 (en) 2011-02-02
TW201002369A (en) 2010-01-16
CN102046171B (zh) 2013-06-19

Similar Documents

Publication Publication Date Title
NL300962I1 (nl) patiromer sorbitex calcium
BRPI0912099A2 (pt) preparação percutaneamente absorvível
BRPI0807453A2 (pt) Preparação sólida
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
BRPI0914745A2 (pt) composição nutricional
DK2340021T3 (da) Substituerede pyrrolidin-2-carboxamider
HUE056626T2 (hu) Antitestkészítmény
BRPI0912213A2 (pt) preparação cosmética
BRPI0917231A2 (pt) composição
IT1392101B1 (it) Composizione comprendente isoflavoni
EP2374452A4 (en) NUTRIENT COMPOSITION
FIC20240018I1 (fi) Vamoroloni
BRPI0914781A2 (pt) Microbiocidas
DK2125048T3 (da) Præparat
DK2276381T3 (da) Drikfremstillingsindretning
BRPI0920287A2 (pt) composição para lavagem de louças
BRPI0911199A2 (pt) microbiocidas
EP2280264A4 (en) STANDARD AGENTS
EP2357204A4 (en) COMPOSITION
BRPI0920833A2 (pt) preparação de benzonorborbenos
FR2940007B1 (fr) Taille-haie
BRPI0912662A2 (pt) trocarte
HRP20170146T1 (hr) Pufa-prekriveni implantati
DK2254963T3 (da) Kerne-skal-flowforbedrer

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: VIDE PARECER NO E-PARECER

B25A Requested transfer of rights approved

Owner name: NITTO DENKO CORPORATION (JP)

B10A Cessation: cessation confirmed

Free format text: HOMOLOGADA A DESISTENCIA DO PEDIDO, SOLICITADA ATRAVES DA PETICAO ELETRONICA WBRJ NO 860140192525 DE 18/11/2014.